BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 29472449)

  • 1. Nrf2 activation attenuates genetic endoplasmic reticulum stress induced by a mutation in the phosphomannomutase 2 gene in zebrafish.
    Mukaigasa K; Tsujita T; Nguyen VT; Li L; Yagi H; Fuse Y; Nakajima-Takagi Y; Kato K; Yamamoto M; Kobayashi M
    Proc Natl Acad Sci U S A; 2018 Mar; 115(11):2758-2763. PubMed ID: 29472449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic adaptation of human skin fibroblasts to ER stress caused by glycosylation defect in PMM2-CDG.
    Zdrazilova L; Rakosnikova T; Himmelreich N; Ondruskova N; Pasak M; Vanisova M; Volfova N; Honzik T; Thiel C; Hansikova H
    Mol Genet Metab; 2023 Aug; 139(4):107629. PubMed ID: 37392701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liposome-encapsulated mannose-1-phosphate therapy improves global N-glycosylation in different congenital disorders of glycosylation.
    Budhraja R; Radenkovic S; Jain A; Muffels IJJ; Ismaili MHA; Kozicz T; Pandey A; Morava E
    Mol Genet Metab; 2024 Jun; 142(2):108487. PubMed ID: 38733638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complex metabolic disharmony in PMM2-CDG paves the way to new therapeutic approaches.
    Himmelreich N; Kikul F; Zdrazilova L; Honzik T; Hecker A; Poschet G; Lüchtenborg C; Brügger B; Strahl S; Bürger F; Okun JG; Hansikova H; Thiel C
    Mol Genet Metab; 2023 Jul; 139(3):107610. PubMed ID: 37245379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptomic analysis identifies dysregulated pathways and therapeutic targets in PMM2-CDG.
    Gallego D; Serrano M; Cordoba-Caballero J; Gámez A; Seoane P; Perkins JR; Ranea JAG; Pérez B
    Biochim Biophys Acta Mol Basis Dis; 2024 Jun; 1870(5):167163. PubMed ID: 38599261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. D-galactose supplementation in individuals with PMM2-CDG: results of a multicenter, open label, prospective pilot clinical trial.
    Witters P; Andersson H; Jaeken J; Tseng L; van Karnebeek CDM; Lefeber DJ; Cassiman D; Morava E
    Orphanet J Rare Dis; 2021 Mar; 16(1):138. PubMed ID: 33743737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperinsulinism May Be Underreported in Hypoglycemic Patients with Phosphomannomutase 2 Deficiency.
    Vurallı D; Yıldız Y; Ozon A; Dursun A; Gönç N; Tokatlı A; Sivri HS; Alikaşifoğlu A
    J Clin Res Pediatr Endocrinol; 2022 Aug; 14(3):275-286. PubMed ID: 35308014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tracer metabolomics reveals the role of aldose reductase in glycosylation.
    Radenkovic S; Ligezka AN; Mokashi SS; Driesen K; Dukes-Rimsky L; Preston G; Owuocha LF; Sabbagh L; Mousa J; Lam C; Edmondson A; Larson A; Schultz M; Vermeersch P; Cassiman D; Witters P; Beamer LJ; Kozicz T; Flanagan-Steet H; Ghesquière B; Morava E
    Cell Rep Med; 2023 Jun; 4(6):101056. PubMed ID: 37257447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AAV9-based
    Zhong M; Balakrishnan B; Guo AJ; Lai K
    Mol Genet Metab Rep; 2024 Mar; 38():101035. PubMed ID: 38130891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. β-Glucose-1,6-Bisphosphate Stabilizes Pathological Phophomannomutase2 Mutants In Vitro and Represents a Lead Compound to Develop Pharmacological Chaperones for the Most Common Disorder of Glycosylation, PMM2-CDG.
    Monticelli M; Liguori L; Allocca M; Andreotti G; Cubellis MV
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31454904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring ligand interactions with human phosphomannomutases using recombinant bacterial thermal shift assay and biochemical validation.
    Monticelli M; Hay Mele B; Wright DM; Guerriero S; Andreotti G; Cubellis MV
    Biochimie; 2024 Jul; 222():123-131. PubMed ID: 38458414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neural and metabolic dysregulation in PMM2-deficient human in vitro neural models.
    Radenkovic S; Budhraja R; Klein-Gunnewiek T; King AT; Bhatia TN; Ligezka AN; Driesen K; Shah R; Ghesquière B; Pandey A; Kasri NN; Sloan SA; Morava E; Kozicz T
    Cell Rep; 2024 Mar; 43(3):113883. PubMed ID: 38430517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRISPR-Generated Nrf2a Loss- and Gain-of-Function Mutants Facilitate Mechanistic Analysis of Chemical Oxidative Stress-Mediated Toxicity in Zebrafish.
    Mills MG; Ramsden R; Ma EY; Corrales J; Kristofco LA; Steele WB; Saari GN; Melnikov F; Kostal J; Kavanagh TJ; Zimmerman JB; Voutchkova-Kostal AM; Brooks BW; Coish P; Anastas PT; Gallagher E
    Chem Res Toxicol; 2020 Feb; 33(2):426-435. PubMed ID: 31858786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurological manifestations in PMM2-congenital disorders of glycosylation (PMM2-CDG): Insights into clinico-radiological characteristics, recommendations for follow-up, and future directions.
    Muthusamy K; Perez-Ortiz JM; Ligezka AN; Altassan R; Johnsen C; Schultz MJ; Patterson MC; Morava E
    Genet Med; 2024 Feb; 26(2):101027. PubMed ID: 37955240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation of sec63 in zebrafish causes defects in myelinated axons and liver pathology.
    Monk KR; Voas MG; Franzini-Armstrong C; Hakkinen IS; Talbot WS
    Dis Model Mech; 2013 Jan; 6(1):135-45. PubMed ID: 22864019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between acute complications in PMM2-CDG patients and haemostasis anomalies: Data from a multicentric study and suggestions for acute management.
    Wicker C; Roux CJ; Goujon L; de Feraudy Y; Hully M; Brassier A; Bérat CM; Chemaly N; Wiedemann A; Damaj L; Abi-Warde MT; Dobbelaere D; Roubertie A; Cano A; Arion A; Kaminska A; Da Costa S; Bruneel A; Vuillaumier-Barrot S; Boddaert N; Pascreau T; Borgel D; Kossorotoff M; Harroche A; de Lonlay P
    Mol Genet Metab; 2023 Nov; 140(3):107674. PubMed ID: 37542768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. trappc11 is required for protein glycosylation in zebrafish and humans.
    DeRossi C; Vacaru A; Rafiq R; Cinaroglu A; Imrie D; Nayar S; Baryshnikova A; Milev MP; Stanga D; Kadakia D; Gao N; Chu J; Freeze HH; Lehrman MA; Sacher M; Sadler KC
    Mol Biol Cell; 2016 Apr; 27(8):1220-34. PubMed ID: 26912795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disruption of the kringle 1 domain of prothrombin leads to late onset mortality in zebrafish.
    Grzegorski SJ; Hu Z; Liu Y; Yu X; Ferguson AC; Madarati H; Friedmann AP; Reyon D; Kim PY; Kretz CA; Joung JK; Shavit JA
    Sci Rep; 2020 Mar; 10(1):4049. PubMed ID: 32132579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Untangling adaptive functioning of PMM2-CDG across age and its impact on parental stress: a cross-sectional study.
    Epifani F; Pujol Serra SM; Llorens M; Balcells S; Nolasco G; Bolasell M; Aguilera-Albesa S; Cancho Candela R; Cuevas Cervera JL; García Sánchez V; Garcia O; Miranda-Herrero MC; Moreno-Lozano PJ; Robles B; Roldán Aparicio S; Velázquez Fragua R; Serrano M
    Sci Rep; 2023 Dec; 13(1):22783. PubMed ID: 38129426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ReBaTSA: A simplified CeTSA protocol for studying recombinant mutant proteins in bacterial extracts.
    Monticelli M; Wright DM; Cubellis MV; Andreotti G
    Biochim Biophys Acta Gen Subj; 2024 Feb; 1868(2):130526. PubMed ID: 38049040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.